| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |